Cardiac involvement in Dutch patients with sarcoglycanopathy: A cross-sectional cohort and follow-up study

Muscle and Nerve

Volumn 50, Issue 6, 2014, Pages 909-913

  Schade van Westrum, Steven M ^a   Dekker, Lukas R C ^b   De Voogt, Willem G ^c   Wilde, Arthur A M ^b   Ginjaar, Ieke B ^d   De Visser, Marianne ^a   Van der Kooi, Anneke J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cohort study; Dilated cardiomyopathy; Follow up; Limb girdle muscular dystrophy; Sarcoglycanopathy

Indexed keywords

ADOLESCENT; ADULT; CARDIOMYOPATHY, DILATED; CHILD; COHORT ANALYSIS; COMPLICATION; CROSS-SECTIONAL STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART; HUMAN; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; SARCOGLYCANOPATHIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; CARDIOMYOPATHY, DILATED; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NETHERLANDS; RETROSPECTIVE STUDIES; SARCOGLYCANOPATHIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84912129521     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24233     Document Type: Article

References (23)

1. Ginjaar HB, van der Kooi AJ, Ceelie H, Kneppers AL, van Meegen M, Barth PG, et al. Sarcoglycanopathies in Dutch patients with autosomal recessive limb girdle muscular dystrophy. J Neurol 2000;247:524-529.
2. Ozawa E, Noguchi S, Mizuno Y, Hagiwara Y, Yoshida M. From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. Muscle Nerve 1998;21:421-438.
3. McNally EM, Passos-Bueno MR, Bonnemann CG, Vainzof M, de Sa Moreira E, Lidov H, et al. Mild and severe muscular dystrophy caused by a single gamma-sarcoglycan mutation. Am J Hum Gen 1996;59:1040-1047.
4. Nigro V, De Sa Moreira E, Piluso G, Vainzof M, Belsito A, Politano L, et al. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat Genet 1996;14:195-198.
5. Van der Kooi A, de Voogt WG, Barth P, Busch H, Jennekens F, Jongen P, et al. The heart in limb girdle muscular dystrophy. Heart 1998;79:73-77.
6. Wheeler MT, McNally EM. ScienceDirect.com - Trends in cardiovascular medicine - sarcoglycans in vascular smooth and striated muscle. Trends Cardiovasc Med 2003;13:238-243.
7. Ozawa E, Mizuno Y, Hagiwara Y, Sasaoka T, Yoshida M. Molecular and cell biology of the sarcoglycan complex. Muscle Nerve 2005;32:563-576.
8. Melacini P, Fanin M, Duggan DJ, Freda MP, Berardinelli A, Danieli GA, et al. Heart involvement in muscular dystrophies due to sarcoglycan gene mutations. Muscle Nerve 1999;22:473-479.
9. Politano L, Nigro V, Passamano L, Petretta V, Comi LI, Papparella S, et al. Evaluation of cardiac and respiratory involvement in sarcoglycanopathies. Neuromuscul Disord 2001;11:178-185.
10. Calvo F, Teijeira S, Fernandez JM, Teijeiro A, Fernandez-Hojas R, Fernandez-Lopez XA, et al. Evaluation of heart involvement in gamma-sarcoglycanopathy (LGMD2C). A study of ten patients. Neuromuscul Disord 2000;10:560-566.
11. Fanin M, Melacini P, Boito C, Pegoraro E, Angelini C. LGMD2E patients risk developing dilated cardiomyopathy. Neuromuscul Disord 2003;13:303-309.
12. Sveen M-L, Thune JJ, Kober L, Vissing J. Cardiac involvement in patients with limb-girdle muscular dystrophy type 2 and Becker muscular dystrophy. Arch Neurol 2008;65:1196-1201.
13. Ben Hamida M, Ben Hamida C, Zouari M, Belal S, Hentati F. Limb-girdle muscular dystrophy 2C: clinical aspects. Neuromuscul Disord 1996;6:493-494.
14. Fadic R, Sunada Y, Waclawik AJ, Buck S, Lewandoski PJ, Campbell KP, et al. Brief report: deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy N Engl J Med 1996;334:362-366.
15. Barresi R, Di Blasi C, Negri T, Brugnoni R, Vitali A, Felisari G, et al. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutations. J Med Genet 2000;37:102-107.
16. Bushby K, Muntoni F, Bourke JP. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. Neuromuscul Disord 2003;13:166-172.
17. Brooke M, Fenichel G, Griggs R, Mendell J. Duchenne muscular dystrophy. Neurology 1989;39:475-481.
18. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 1980;62:1054-1061.
19. WHO ISFC TF. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980;44:672-673.
20. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107-133.
21. Khouri SJ, Maly GT, Suh DD, Walsh TE. A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr 2004;17:290-297.
22. Townsend D, Yasuda S, McNally E, Metzger JM. Distinct pathophysiological mechanisms of cardiomyopathy in hearts lacking dystrophin or the sarcoglycan complex. FASEB J 2011;25:3106-3114.
23. Lancioni A, Rotundo IL, Kobayashi YM, D'Orsi L, Aurino S, Nigro G, et al. Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex. Hum Mol Genet 2011;20:4644-4654.